Kilambi News
Sunday, November 22, 2026

Archive

Every story, newest first.

Sunday, November 1, 2026

Commodities

Tanker freight climbs as Hormuz risk is repriced

The site tanker freight index rose 2.05 percent on Friday to 968.92 dollars and is up 8.06 percent on the week, while dry bulk freight fell 2.25 percent to 12.19 dollars.

Commodities

Propane leads weekly NGL surge on export demand

United States propane rose 21.0 percent in the week to Friday, with normal butane up 18.0 percent and ethane up 11.3 percent, on strong export demand and inventory draws, Morgan Downey's weekly commodity review reported.

Life Sciences

Regeneron third quarter revenue jumps 36 percent on Sanofi share

Regeneron reported third quarter revenue up 36 percent to 5.1 billion dollars, with non-GAAP earnings per share up 70 percent to 20.07 dollars, and expanded its Sanofi antibody collaboration with a 1.0 billion dollar upfront payment due in the fourth quarter.

Life Sciences

Insmed raises Brinsupri guidance after blockbuster first year

Insmed reported third quarter revenue of 524.4 million dollars, up 268 percent year over year, with Brinsupri at 400.1 million dollars in the quarter and more than 1 billion dollars in its first four full quarters, and raised 2026 Brinsupri guidance to 1.35 billion to 1.4 billion dollars.

Life Sciences

FDA approves Sun Pharma Ilumya for psoriatic arthritis

The FDA approved Sun Pharma's Ilumya (tildrakizumab-asmn) for adults with active psoriatic arthritis on October 30, adding a second disease to a label first cleared for plaque psoriasis in 2018.

Life Sciences

EMA validates Immunome varegacestat application for desmoid tumours

The European Medicines Agency validated Immunome's marketing authorisation application for varegacestat in adults with desmoid tumours, starting the centralised review of a drug whose Phase 3 trial cut the risk of progression or death by 84 percent.

Life Sciences

Also notable in life sciences on November 1

Five smaller life sciences items on November 1 include feature reporting on the FDA attempt to withdraw Amgen's Tavneos, a STAT panel on the health policy stakes of the midterms, and a reported share surge of about 257 percent in Inovio after its Voceryq approval.

Politics

Tens of thousands rally in Delhi demanding election chief resign

Tens of thousands rallied at Ramlila Maidan in Delhi on Sunday demanding that Chief Election Commissioner Gyanesh Kumar resign over a voter roll revision that has struck 130 million names from draft lists.

Rates

China to meet major banks on stock market support

China's central bank will meet the country's financial and securities regulators and major banks on Monday to discuss capital market support tools, including improving the relending program for share buybacks and stake increases, Bloomberg reported, citing a Cailian report based on unnamed industry sources.

Rates

Saudi economy contracts 3.8 percent in third quarter

Saudi Arabia's real GDP fell 3.8 percent year on year in the third quarter of 2026, a second straight contraction, as oil activities dropped 20.4 percent amid the Hormuz disruption while non-oil activities grew 1.9 percent, according to GASTAT flash estimates.